Mark Fishman

Insider Reports History

Entity
Individual
Location
C/O Beam Therapeutics Inc., 26 Landsdowne Street, Cambridge, MA
Signature
By: /s/ Christine Bellon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Fishman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 23.1K $564K $24.40 Jun 5, 2024 Direct

Insider Reports Filed by Mark Fishman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
BEAM Beam Therapeutics Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director